Polyol pathway and modulation of ischemia-reperfusion injury in Type 2 diabetic BBZ rat hearts

Cardiovascular Diabetology

Volumn 7, Issue , 2008, Pages

  Li, Qing ^a   Hwang, Yuying C ^a   Ananthakrishnan, Radha ^a   Oates, Peter J ^b   Guberski, Dennis ^c   Ravichandran, Ramasamy ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^c Biomedical Research Models Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; IDITOL DEHYDROGENASE; POLYOL; ADENOSINE TRIPHOSPHATE; LACTIC ACID DERIVATIVE; POLYMER; PYRUVIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DISEASE DURATION; ENZYME RELEASE; HEART FUNCTION; HEART INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RAT STRAIN; REPERFUSION INJURY; TISSUE LEVEL; WESTERN BLOTTING; ANIMAL; BIOBREEDING RAT; DISEASE MODEL; HEART MUSCLE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ALDEHYDE REDUCTASE; ANIMALS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; L-IDITOL 2-DEHYDROGENASE; LACTATES; MYOCARDIUM; POLYMERS; PYRUVATES; RATS; RATS, INBRED BB; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 56649108242     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-7-33     Document Type: Article

References (53)

1. Stone GW Grines CL Browne KF Marco J Rothbaum D O'Keefe J Hartzler GO Overlie P Donohue B Chelliah N Timmis GC Vliestra R Strezelecki M Puchrowicz-Ochocki S O'Neill WW Predictors of in-hospital and 6-minth outcome after acute myocardial infarction in the reperfusion era: The primary angioplasty in myocardial infarction (PAMI) trial J Am Coll Cardiol 1995, 25:370-377. 10.1016/0735-1097(94)00367-Y 7829790
2. Garcia MJ McNamara PM Grodon T Kannal WB Morbidity and mortality in the Framingham population: Sixteenyear follow-up study Diabetes 1974, 23:105-111. 4359625
3. Jaffe AS Spadaro JJ Schetman R Roberts R Geltman EM Sobel BE Increased congestive heart failure after myocardial infarction of moderate extent in patients with diabetes mellitus Am Heart J 1984, 108:31-37. 10.1016/ 0002-8703(84)90541-6 6731279
4. Lehto S Pyorala K Miettinen H Ronnemaa T Palomaki P Tuomilehto J Laakso M Myocardial infarct size and mortality in patients with non- insulin-dependent diabetes mellitus J Intern Med 1994, 236(3):291-297. 8077886
5. Woodfield SL Lundergan CF Reiner JS Greenhouse SW Thompson MA Rohrbeck SC Deychak Y Simoons ML Califf RM Topol EJ Ross AM Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: The GUSTO-1 experience J Am Coll Cardiol 1996, 28:1661-1669. 10.1016/S0735-1097(96)00397-X 8962549
6. Frustaci A Kajstura J Chimenti C Jakoniuk I Leri A Maseri A Nadal-Ginard B Anverse P Myocardial cell death in human diabetes Circ Res 2000, 87:1123-1132. 11110769
7. Shedaheh A Regan TJ Cardiac consequences of diabetes mellitus Clin Cardiol 1995, 18:301-305. 7664503
8. Anzawa R Seki S Horikoshi K Taniguchi M Mochizuki S Exacerbation of acidosis during ischemia and reperfusion arrhythmia in hearts from type 2 Diabetic Otsuka Long-Evans Tokushima Fatty rats Cardiovasc Diabetol 2007, 6:17. 1896150 17550619 10.1186/1475-2840-6-17
9. Wang P Chatham JC Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart Am J Physiol Endocrinol Metab 2004, 286:E725-736. 10.1152/ ajpendo.00295.2003 14722022
10. Chandler MP Morgan EE McElfresh TA Kung TA Rennison JH Hoit BD Young ME Heart failure progression is accelerated following myocardial infarction in type 2 diabetic rats Am J Physiol Heart Circ Physiol 2007, 293:H1609-1616. 10.1152/ajpheart.01338.2006 17545473
11. Desrois M Sidell RJ Gauguier D King LM Radda GK Clarke K Initial steps of insulin signaling and glucose transport are defective in the type 2 diabetic rat heart Cardiovasc Res 2004, 61:288-296. 10.1016/ j.cardiores.2003.11.021 14736545
12. Kristiansen SB Lofgren B Stottrup NB Khatir D Nielsen-Kudsk JE Nielsen TT Botker HE Flyvbjerg A Ischemic preconditioning does not protect the heart in obese and lean animal models of Type 2 diabetes Diabetologia 2004, 47:1716-1721. 10.1007/s00125-004-1514-4 15480537
13. Ellis EA Guberski DL Somogyi-Mann M Grant MB Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat Free Radical Biology Medicine 2000, 28:91-101. 10.1016/ S0891-5849(99)00216-6 10656295
14. Sima AAF Zhang W Sugimoto K Guberski DL Yorek BM A comparison of diabetic polyneuropathy in Type 2 diabetic BBZDR/Wor rats and in Type 1 diabetic BB/Wor rats Diabetologia 2000, 43:786-793. 10.1007/ s001250051376 10907124
15. Tirabassi RS Flanagan JF Wu T Kislauskis EH Birckbichler PJ Guberski DL The BBZDR/Wor rat model for investigating the complications of type 2 diabetes mellitus ILAR J 2004, 45:292-302. 15229376
16. Harrison DH Bohren KM Ringe D Petsko GA Gabbay KH An anion binding site in human aldose reductase: Mechanistic implications for the binding of citrate, cacodylate, and glucose-6-phosphate Biochemistry 1994, 33:2011-2020. 10.1021/bi00174a006 8117658
17. Busik JV Hootman SR Greenidge CA Henry DN Glucose-specific regulation of aldose reductase in Capan-1 human pancreatic duct cells in vitro J Clin Invest 1997, 100:1685-1692. 508351 9312166 10.1172/JCI119693
18. Srivastava SK Ansari NH Hair GA Awasthi S Das B Activation of human erythrocyte, brain, aorta, muscle, and occular tissue aldose reductase Metabolism 1986, 35:114-118. 10.1016/0026-0495(86)90199-X 3083202
19. Grimshaw CE Bohren KM Lai CJ Gabbay KH Human aldose reductase: PK of tyrosine 48 reveals the preferred ionization state for catalysis and inhibition Biochemistry 1995, 34:14374-14384. 10.1021/bi00044a014 7578041
20. Grimshaw CE Bohren KM Lai CJ Gabbay KH Human aldose reductase: Subtle effects revealed by rapid kinetic studies of the C298A mutant enzyme Biochemistry 1995, 34:14366-14373. 10.1021/bi00044a013 7578040
21. Ramasamy R Oates PJ Aldose reductase and vascular stress Text Book of Diabetes Mellitus and Cardiovascular Disease Lippincott Williams & Wilkins, Philadelphia, USA Marso SP, Stern DM 2003:55-74.
22. Kador PF Kinoshita JH Role of aldose reductase in the development of diabetes associated complications Am J Med 1985, 79:8-12. 10.1016/ 0002-9343(85)90504-2 3934965
23. Kador PF The role of aldose reductase in the development of diabetic complications Med Res Rev 1988, 8:325-352. 10.1002/med.2610080302 3136278
24. Gabbay KH The polyol pathway and the complications of diabetes N Engl J Med 1973, 288:831-836. 4266466
25. Kinoshita JH Nishimura C The involvement of aldose reductase in diabetic complications Diabetes Metab Rev 1988, 4:323-337. 3134179
26. Greene DA Sima AAF Stevens MJ Feldman EL Killen PD Henry DN Thomas T Dananberg J Lattimer SA Aldose reductase inhibitors: An approach to the treatment of diabetic nerve damage Diabetes Metab Rev 1993, 9:189-217. 8187607
27. Ramasamy R Oates PJ Schaefer S Aldose reductase inhibition protects diabetic and non-diabetic rat hearts from ischemic injury Diabetes 1997, 46:292-300. 10.2337/diabetes.46.2.292 9000707
28. Ramasamy R Trueblood NA Schaefer S Metabolic effects of aldose reductase inhibition during low-flow ischemia and reperfusion Am J Physiol 1998, 275:H195-H203. 9688914
29. Ramasamy R Hwang YC hang J Bergmann SR Protection of ischemic hearts by high glucose is mediated, in part, by GLUT-4 Am J Physiol Heart Circ Physiol 2001, 281(1):H290-H297. 11406496
30. Ramasamy R Hwang YC Bakr S Bergmann SR Protection of ischemic hearts perfused with an anion exchange inhibitor, DIDS, is associated with beneficial changes in substrate metabolism Cardiovasc Res 2001, 51:275-282. 10.1016/S0008-6363(01)00301-7 11470467
31. Inskeep PB Reed AE Ronfeld RA Pharmacokinetics of zopolrestat, a carboxylic acid aldose reductase inhibitor, in normal and diabetic rats Pharmaceut Res 1991, 8:1511-1515. 10.1023/A:1015894300247
32. Hwang YC Kaneko M Bakr S Liao H Lu Y Lewis ER Yan SD Ii S Itakura M Rui L Skopicki H Homma S Schmidt AM Oates PJ Szabolcs M Ramasamy R Central role for aldose reductase pathway in myocardial ischemic injury FASEB J 2004, 18:1192-1199. 10.1096/fj.03-1400com 15284219
33. Hwang YC Sato S Tsai JY Bakr S Yan SD Oates PJ Ramasamy R Aldose reductase activation is a key component of myocardial response to ischemia FASEB 2002, 16:243-245. 10.1096/fj.01-0732com
34. Hwang YC Bakr S Ellery CR Oates PJ Ramasamy R Sorbitol dehydrogenase: A novel target for adjunctive protection of ischemic myocardium FASEB J 2003, 17:2331-2333. 14525943
35. Trueblood NA Ramasamy R Aldose reductase inhibition improves the altered glucose metabolism of isolated diabetic rat hearts Am J Physiol 1998, 275:H75-H83. 9688898
36. Tekin D Xi L Zhao T Tejero-Taldo MI Atluri S Kukreja RC Mitogen-activated protein kinases mediate heat shock induced delayed protection in mouse heart Am J Physiol Heart Circ Physiol 2001, 281(2):H523-H532. 11454553
37. Peterson RG Shaw WN Neel MA Little LA Eichberg J Zucker diabetic fatty rat asa model for non-insulin-dependent diabetes mellitus ILAR News 1990, 32:16-19.
38. Zhou YT Grayburn P Karim A Shimabukuro M Higa M Baetens D Orci L Unger RH Lipotoxic heart disease in obese rats: Implications for human obesity Proc Natl Acad Sci USA 2000, 97:1784-1789. 26513 10677535 10.1073/ pnas.97.4.1784
39. Williamson JR Chang K Frangos M Hasan KS Ido Y Kawamura T Nyengaard JR Enden Van den M ilo C Tilton RG Hyperglycemic pseudohypoxia and diabetic complications Diabetes 1993, 42:801-813. 10.2337/diabetes.42.6.801 8495803
40. Tilton RG Baier LD Harlow JE Smith SR Ostrow E Williamson JR Diabetes-induced glomerular dysfunction: Links to a more reduced cytosolic ratio of NADH/NAD+ Kidney Int 1992, 41:778-788. 10.1038/ ki.1992.121 1513100
41. Obrosova I Faller A Burgan J Ostrow E Williamson JR Glycolytic pathway, redox state of NAD(P)-couples and energy metabolism in lens in galactose-fed rats: Effect of an aldose reductase inhibitor Curr Eye Res 1997, 16:34-43. 10.1076/ceyr.16.1.34.5113 9043821
42. Schmidt RE Dorsey DA Beaudet LN Parvin CA Yarasheski KE Smith SR Williamson JR Peterson RG Oates PJ A potent sorbitol dehydrogenase inhibitor exacerbates sympathetic autonomic neuropathy in rats with streptozotocin-induced diabetes Experimental Neurology 2005, 192:407-419. 10.1016/j.expneurol.2004.12.018 15755558
43. Schmidt RE Dorsey DA Beaudet LN Plurad SB Parvin CA Yarasheski KE Smith SR Lang H Williamson JR Ido Y Inhibition of sorbitol dehydrogenase exacerbates autonomic neuropathy in rats with streptozotocin-induced diabetes J Neuropathol Exp Neurol 2001, 60(12):1153-1169. 11764088
44. Steenbergen C Murphy E Watts JA London RE Correlation between cystolic free calcium, contracture, ATP, and irreversible ischemic injury in perfused rat heart Circ Res 1990, 66:135-146. 2295135
45. Steenbergen C Perlman ME London RE Murphy E Mechanism of preconditioning: Ionic alterations Circ Res 1993, 72:112-125. 8380259
46. Ramasamy R Liu H Anderson S Lundmark J Schaefer S Ischemic preconditioning stimulates sodium and proton transport in the isolated rat heart J Clin Invest 1995, 96:1464-1472. 185770 7657818 10.1172/ JCI118183
47. Anderson SE Murphy E Steenbergen C London RE Cala PM Na-H exchange in myocardium: Effects of hypoxia and acidification on Na and Ca Am J Physiol 1990, 259:C940-C948. 2175547
48. Ramasamy R Liu H Oates PJ Schaefer S Attenuation of ischemia induced increases in sodium and calcium by an aldose reductase inhibitor zopolrestat Cardiovasc Res 1999, 42:130-139. 10.1016/ S0008-6363(98)00303-4 10435004
49. Ramasamy R Schaefer S Inhibition of Na+-H+ exchanger protects diabetic and non-diabetic hearts from ischemic injury: Insight into altered susceptibility of diabetic hearts to ischemic injury J Mol Cell Cardiol 1999, 31:785-797. 10.1006/jmcc.1998.0908 10329206
50. Yue TL Bao W Gu JL Cui J Tao L Ma XL Ohlstein EH Jucker BM Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/ reperfusion-induced myocardial injury Diabetes 2005, 54:554-562. 10.2337/ diabetes.54.2.554 15677515
51. Iwata K Matsuno K Nishinaka T Persson C Yabe-Nishimura C Aldose reductase inhibitors improve myocardial reperfusion injury in mice by a dual mechanism J Pharmacol Sci 2006, 102(1):37-46. 10.1254/ jphs.FP0060218 16936455
52. Tracey WR Magee WP Ellery CA MacAndrew JT Smith AH Knight DR Oates PJ Aldose reductase inhibition alone or combined with an adenosine A(3) agonist reduces ischemic myocardial injury Am J Physiol Heart Circ Physiol 2000, 279(4):H1447-1452. 11009428
53. Johansen JS Harris AK Rychly DJ Ergul A Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice Cardiovasc Diabetol 4(1):5. 2005 Apr 29 1131912 15862133 10.1186/ 1475-2840-4-5